pyrazinamide has been researched along with kanamycin a in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 96 (72.18) | 18.7374 |
1990's | 2 (1.50) | 18.2507 |
2000's | 7 (5.26) | 29.6817 |
2010's | 27 (20.30) | 24.3611 |
2020's | 1 (0.75) | 2.80 |
Authors | Studies |
---|---|
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Chegaev, K; Chung, MC; de Souza, PC; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Lazzarato, L; Marino, LB; Pavan, FR | 1 |
Bhosle, GS; Fernandes, M; Nawale, L; Sarkar, D; Yeware, AM | 1 |
Bera, S; Mondal, D | 1 |
Mabhula, A; Singh, V | 1 |
Bates, JH | 1 |
Newton, RW | 1 |
Bialik, IB; Khutorskaia, VD; Mamolat, AS | 1 |
Holdiness, MR | 1 |
Heap, BJ | 1 |
Krivinka, R; Tousek, J | 1 |
Wilson, TM | 1 |
Flemming, J; Virchow, C | 1 |
Almeyda, J; Levantine, A | 1 |
Horsfall, PA | 1 |
Mühlberger, F | 1 |
Jentgens, H | 1 |
Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
Kotliarov, LM; Pavlov, EP; Tushov, EG | 1 |
Degtiarev, VP | 1 |
Dye, WE | 1 |
Gartmann, JC | 2 |
Naegeli, HR | 1 |
Clark, J; Wallace, A | 1 |
Bayliss, CG | 1 |
Steiner, M | 1 |
Ovreberg, K | 1 |
Berktin, K | 1 |
Grumbach, F | 1 |
Drabkina, RO; Ginzburg, TS | 2 |
Iaschenko, BP | 1 |
Steininger, WJ | 1 |
Bernard, E | 1 |
Zierski, M | 1 |
Lucchesi, M; Mancini, P; Matzeu, M | 1 |
Jesiotr, M | 1 |
Lester, W | 2 |
Suzuki, T | 1 |
Bialik, IB | 1 |
Bethge, H | 1 |
Ota, Y | 2 |
Burgher, LW; Kass, I | 1 |
Wolinsky, E | 2 |
Koĭfman, SG; Man'kovetskiĭ, EF; Sirota, DS; Vatsyk, MZ | 1 |
Ellorhaoui, M; Storch, W; Tauchnitz, C | 1 |
Kass, I | 3 |
Sunahara, S | 1 |
Hokama, S | 2 |
Kaminskaia, GO; Karachunskiĭ, MA; Kolosovskaia, VP | 1 |
Allan, GW; Lees, AW; Smith, J; Tyrrell, WF | 1 |
Urbancik, B | 1 |
Costa, JA; Cunha, JM; Mac Dowell, A; Pannain, M; Pantoja, W; Tarantino, AB | 1 |
Golitsina, LV; Kaminskaia, AA; Korotaev, GA; Utkin, VV | 1 |
Fegiz, G | 1 |
Dye, WE; Fischer, DA; Lester, W; Moulding, TS | 1 |
Organick, AB; Wilson, EM | 1 |
Freerksen, E | 1 |
Dambrosi, A; Dambrosi, VM; Gonzalez Montaner, LJ; Manassero, M | 1 |
Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
GILL, R; HAAPANEN, J; KASS, I; RUSSELL, WF | 1 |
HEYMER, A | 1 |
HURNI, H | 1 |
BOSZORMENYI, M | 1 |
CATTANEO, C; DE SIMONI, G | 1 |
TSUCHIMOCHI, T | 1 |
KITAMOTO, O | 1 |
RUSSO, V | 1 |
PFUETZE, KH; PYLE, MM | 1 |
GRECO, S; MUSSOMELI, A | 1 |
BEK, E | 1 |
BANCALE, A; LUCCHESI, M; ROSSI, P | 1 |
WONG, PC | 1 |
BROUET, G; MARCHE, J | 1 |
BERNARD, E; PIERON, R | 1 |
CSERNUS, A; SZENDROEI, Z | 1 |
SCHWARTZ, WS | 1 |
ACEVEDO, RC; HERRERO, JJ; PILHEU, J; RODRIGUEZ, E | 1 |
BRONSTEIN, DL; CONTRERAS, H; FARIAS, CE; MUNARO, N; PEREZ, JA | 1 |
CHAVES, AD | 1 |
ALBRECHT, KF | 1 |
SUTINEN, S; TUOVINEN, PI | 1 |
LESTON, JM | 1 |
COMENALE, D; FILLA, E; ROSSI, F | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
JANCIK, E; NOVAK, M | 1 |
CORNU, P; FOUQUET, J | 1 |
CHAPMAN, PT; MEDINA, G | 1 |
HORNE, NW | 1 |
ALLISON, RF; INGLIS, RM; SCHLESS, JM; TOPPERMAN, S; WHITE, EF | 1 |
Han, L; Lee, DH; Lee, WC; Mitnick, CD; Park, SK; Seung, KJ | 1 |
Krasnov, VA; Ursov, IG | 1 |
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A | 1 |
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S | 1 |
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
Aung, KJ; Das, PK; Declercq, E; Hossain, MA; Rieder, HL; Sarker, MR; Van Deun, A | 1 |
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A | 1 |
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V | 1 |
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
Chung, JY; Jang, IJ; Jang, K; Lee, JH; Moon, SJ; Oh, J; Park, JS; Park, SI; Song, J; Yoon, J; Yu, KS | 1 |
Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R | 1 |
Karak, A; Mukhopadhay, S; Paul, R; Santra, G | 1 |
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA | 1 |
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M | 1 |
Dhamija, RK; Garg, D; Saroha, D; Singh, AK | 1 |
11 review(s) available for pyrazinamide and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1967 |
[Chemotherapeutic studies on advanced tuberculosis in mice].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mice; Models, Biological; Phenazines; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1965 |
[COMPLICATIONS OF A METABOLIC AND ENDOCRINE NATURE PRODUCED BY ANTIBACILLARY CHEMOTHERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Avitaminosis; Cycloserine; Endocrinology; Ethionamide; Isoniazid; Kanamycin; Metabolic Diseases; Niacin; Niacinamide; Pyrazinamide; Streptomycin; Sulfones; Thiosemicarbazones; Toxicology; Viomycin; Vitamin B 6 Deficiency | 1964 |
[UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Serologic Tests; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Urogenital; Urine | 1964 |
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis | 2010 |
4 trial(s) available for pyrazinamide and kanamycin a
Article | Year |
---|---|
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2011 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Area Under Curve; Cycloserine; Drug Monitoring; Fluoroquinolones; Healthy Volunteers; Humans; Kanamycin; Levofloxacin; Male; Moxifloxacin; Prothionamide; Pyrazinamide; Streptomycin; Young Adult | 2015 |
118 other study(ies) available for pyrazinamide and kanamycin a
Article | Year |
---|---|
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Humans; Mycobacterium tuberculosis; Oxadiazoles | 2016 |
Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life.
Topics: Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Microbial Sensitivity Tests; Molecular Structure; Particle Size; Peptidomimetics; Structure-Activity Relationship; Tuberculosis | 2018 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
[Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
Topics: Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Prothionamide; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1976 |
[Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethionamide; Female; Humans; Kanamycin; Male; Pyrazinamide; Tuberculosis, Pulmonary | 1979 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Pyrazinamide; Rifampin | 1989 |
The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Chronic Disease; Cycloserine; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Meningitis; Middle Aged; Pyrazinamide; Radiography; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
Clinical experience with ethambutol.
Topics: Aminosalicylic Acids; Blood Chemical Analysis; Capreomycin; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
Clinical results of rifampicin treatment.
Topics: Administration, Oral; Adult; Aged; Capreomycin; Chronic Disease; Drug Combinations; Ethambutol; Female; Humans; Kanamycin; Lung; Male; Middle Aged; Mycobacterium tuberculosis; Oxytetracycline; Pyrazinamide; Radiography; Rifampin; Sputum; Time Factors; Tuberculosis, Pulmonary | 1970 |
Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Resistance, Microbial; Ethionamide; Female; Gastrointestinal Diseases; Humans; Kanamycin; Male; Middle Aged; Psychoses, Substance-Induced; Pyrazinamide; Thioacetazone; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Drugs for tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1968 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
[Effect of rifampicin on the intra- and extracellularly located Mycobacterium tuberculosis].
Topics: Animals; Cells, Cultured; Drug Resistance, Microbial; Kanamycin; Mice; Mycobacterium tuberculosis; Phagocytosis; Pyrazinamide; Rifampin; Spleen; Streptomycin | 1974 |
[Results of outpatient treatment of tuberculous patients in a rural area of the Moldavian SSR].
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Moldova; Pyrazinamide; Rural Health; Streptomycin; Thiosemicarbazones; Tuberculosis | 1974 |
Bacteriology of tuberculosis with special reference to kanamycin and related drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis; Viomycin | 1966 |
[Therapy of pulmonary tuberculosis in its current aspects].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1965 |
[Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis].
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Thiosemicarbazones; Viomycin | 1966 |
The susceptibility of mycobacteria to rifamide and rifampicin.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1967 |
Treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1967 |
[Treatment with secondary antitubercular agents].
Topics: Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Time Factors; Viomycin | 1968 |
[The drug treatment of renal tuberculosis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Renal; Ureteral Obstruction; Viomycin | 1967 |
[Minor tuberculostatic drugs].
Topics: Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Viomycin | 1967 |
[Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations].
Topics: Animals; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Mice; Mycobacterium tuberculosis; Oxytetracycline; Pyrazinamide; Tic Disorders; Viomycin | 1966 |
[Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
Topics: Aged; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1967 |
Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Thiosemicarbazones; Tuberculosis, Pulmonary; United States; United States Public Health Service; Viomycin | 1968 |
[Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1968 |
The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Viomycin | 1968 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1969 |
Chemotherapy of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antitubercular Agents; Body Weight; Ethambutol; Ethionamide; Injections, Intramuscular; Kanamycin; Lung; Mice; Organ Size; Pyrazinamide; Rifampin; Spleen; Tuberculosis; Viomycin | 1971 |
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Topics: Adolescent; Adult; Albuminuria; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Eosinophilia; Ethionamide; Headache; Hearing Disorders; Hematuria; Humans; Isoniazid; Kanamycin; Lung Diseases; Middle Aged; Mycobacterium tuberculosis; Pruritus; Pyrazinamide; Respiratory Therapy; Tachycardia; Thiosemicarbazones; Time Factors; Tinnitus; Tuberculosis, Pulmonary; Vertigo; Vestibule, Labyrinth; Viomycin | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
[Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Sulfisoxazole; Tetracycline; Viomycin | 1971 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
Topics: Adult; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Evaluation; Ethambutol; Ethionamide; Female; Hospitals, Special; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary; Viomycin | 1974 |
[Chronic tuberculous meningitis in a case of known Mycobacterium kansasii infection].
Topics: Adult; Burns; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Lymphocytes; Male; Mycobacterium; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Uveitis | 1974 |
Kanamycin in the therapy of pulmonary tuberculosis in the United States.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; United States; Vestibulocochlear Nerve | 1966 |
[Refractory tuberculosis: concept and clinical cases].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Female; Humans; Kanamycin; Male; Mycobacterium tuberculosis; Pneumothorax, Artificial; Pyrazinamide; Streptomycin; Sulfisoxazole; Tuberculosis, Pulmonary | 1971 |
[Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis | 1971 |
[Tuberculostatic activity of the 2d line drugs].
Topics: Animals; Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Mice; Pyrazinamide; Time Factors | 1971 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Male; Mice; Mycobacterium; Pyrazinamide; Streptomycin; Tuberculosis | 1967 |
Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1967 |
[Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Liver; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Ethambutol in the retreatment of chronic pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Depression, Chemical; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
Topics: Adult; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
[Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Delayed-Action Preparations; Ethionamide; Female; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Tuberculosis, Pulmonary | 1967 |
[Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
Topics: Antitubercular Agents; Chlortetracycline; Cycloserine; Ethionamide; Humans; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary | 1967 |
[Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Kanamycin; Phenylthiourea; Pyrazinamide; Tuberculosis, Pulmonary | 1967 |
Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Kanamycin; Pyrazinamide | 1968 |
Multiple drugs in retreatment of chronic pulmonary tuberculosis. Results with capreomycin and ethambutol.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Kanamycin; Male; Middle Aged; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
[Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Topics: Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary | 1968 |
[Colloquium on class II antitubercular agents].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifampin | 1969 |
[Experimental therapy with so-called "minor" tuberculostatics].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Guinea Pigs; Kanamycin; Mice; Phenylthiourea; Pyrazinamide; Rabbits; Tuberculosis; Tuberculosis, Avian | 1966 |
Adverse effects of antituberculosis drugs causing changes in treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid.
Topics: Anti-Bacterial Agents; Bacillus; Cycloserine; Humans; Isoniazid; Kanamycin; Pyrazinamide; Retreatment; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[The importance of medical treatment of pulmonary tuberculosis from a new viewpoint].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Dihydrostreptomycin Sulfate; Ethionamide; Iproniazid; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1962 |
[On new tuberculostatic agents].
Topics: Anilides; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Kanamycin; Pyrazinamide; Rifamycins | 1963 |
[Secondary antitubercular agents].
Topics: Antitubercular Agents; Ethionamide; Humans; Kanamycin; Pyrazinamide; Thiosemicarbazones; Viomycin | 1963 |
[Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
Topics: Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1962 |
[EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacillus; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Research; Streptomycin; Thiosemicarbazones | 1963 |
[SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis, Pulmonary | 1963 |
MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Streptomycin; Thioacetazone; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1963 |
[CHEMO-ANTIBIOTIC THERAPY IN PULMONARY TUBERCULOSIS].
Topics: Antitubercular Agents; Cycloserine; Ethionamide; Kanamycin; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1963 |
RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Prednisone; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pleural; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; Viomycin | 1964 |
[OUR RESULTS IN CHEMO-ANTIBIOTIC THERAPY OF SILICOTUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Silicotuberculosis; Streptomycin; Toxicology | 1963 |
[INTOLERANCE AND TOXICITY OF SUBSTITUTE ANTIBACTERIAL DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Ethionamide; Feeding and Eating Disorders; Hepatitis; Isoniazid; Joint Diseases; Kanamycin; Nausea; Psychoses, Substance-Induced; Psychotic Disorders; Pyrazinamide; Streptomycin; Toxicology; Vertigo; Viomycin | 1963 |
[ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Collapse Therapy; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1963 |
ANONYMOUS MYCOBACTERIA ISOLATED FROM CLINICAL SPECIMENS IN HONG KONG.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; China; Drug Resistance; Drug Resistance, Microbial; Hong Kong; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Pyrazinamide; Research; Streptomycin; Thiosemicarbazones | 1964 |
[THE USE OF ANTIBACILLARY DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Nephrectomy; Nephritis; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Renal; Tuberculosis, Urogenital; Viomycin | 1964 |
[THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Antitubercular Agents; Bacteriology; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Statistics as Topic; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[ASSOCIATION OF 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND PYRAZINAMIDE, AND 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND KANAMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE 1ST LINE DRUGS].
Topics: Antitubercular Agents; Bacteria; Bacteriology; Drug Resistance; Drug Resistance, Microbial; Kanamycin; Phenylthiourea; Pyrazinamide; Radiography, Thoracic; Sputum; Toxicology; Tuberculosis, Pulmonary | 1964 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Pharmacology; Prognosis; Pyrazinamide; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Viomycin | 1964 |
[DRUG TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Phenylthiourea; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Renal; Viomycin | 1964 |
[NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
Topics: Cycloserine; Ethionamide; Kanamycin; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabolism; Cycloserine; Diabetes Mellitus; Drug Tolerance; Ethionamide; Humans; Isoniazid; Kanamycin; Pharmacology; Pyrazinamide; Rifamycins; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacillus; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Geriatrics; Isoniazid; Kanamycin; Pyrazinamide; Sputum; Streptomycin; Thiosemicarbazones; Toxicology; Tuberculosis; Viomycin | 1964 |
[TUBERCULOUS MENINGITIS WITH RESISTANT KOCH BACILLI; RECOVERY OWING TO CYCLOSERINE-PYRAZINAMIDE COMBINATION].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Synergism; Drug Therapy; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Meningeal | 1964 |
DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS.
Topics: Cycloserine; Drug Combinations; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Drug Tolerance; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1965 |
CHEMOTHERAPY OF TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Classification; Cycloserine; Drug Therapy; Ethionamide; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Rest; Social Isolation; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Viomycin | 1964 |
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Hepatomegaly; Isoniazid; Kanamycin; Liver Function Tests; Pharmacology; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1965 |
CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
Topics: Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Kanamycin; Pyrazinamide; Retreatment; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1965 |
CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
Topics: Antitubercular Agents; Capreomycin; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Kanamycin; Phenylthiourea; Pyrazinamide; Retreatment; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1965 |
[COMBINED EFFECT OF ETHIONAMIDE AND PYRAZINAMIDE OR KANAMYCIN ON THE COURSE OF EXPERIMENTAL CHRONIC TUBERCULOSIS IN GUINEA PIGS].
Topics: Animals; Ethionamide; Guinea Pigs; Kanamycin; Pyrazinamide; Research; Tuberculosis | 1965 |
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Cycloserine; Female; Humans; Kanamycin; Korea; Male; Middle Aged; Ofloxacin; Prothionamide; Pyrazinamide; Retrospective Studies; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Bactericidal therapy in patients with tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Chlortetracycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2004 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bangladesh; Child; Clofazimine; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Kanamycin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult | 2014 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Gitelman-like Syndrome with Kanamycin Toxicity.
Topics: Adult; Alkalosis; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Hypokalemia; Kanamycin; Moxifloxacin; Muscle Cramp; Potassium; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Cycloserine; Deprescriptions; Diarylquinolines; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Linezolid; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pyrazinamide; Pyridoxine; Tuberculosis, Pulmonary | 2020 |